News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Antonio Calles: Choose your path after MARIPOSA and COCOON trial presentations at ELCC25
Antonio Calles/X
Mar 28, 2025, 15:18

Antonio Calles: Choose your path after MARIPOSA and COCOON trial presentations at ELCC25

Antonio Calles, Head of the Lung Cancer Unit at Hospital Ruber Internacional, shared a post on X:

“So this is the situation in Paris tonight after high OS MARIPOSA trial and low toxicity within COCOON trial presentations.

Choose your path.”

More posts featuring Antonio Calles.

Antonio Calles cancer COCOON ELCC25 MARIPOSA OncoDaily Oncology
Special Coverage
Science
Apr 20, 2025, 15:09
Vidith Phillips: AI is flooding healthcare journals, but which papers can you actually trust?
Blog
Apr 20, 2025, 14:56
Yan Leyfman: Promising results from CD19 CAR-NK Cell therapy trial
Blog
Apr 20, 2025, 14:41
Vun-Sin Lim: Vote for Alex Adjei for President-Elect in the 2025 IASLC Board of Directors election
Blog
Apr 20, 2025, 14:19
Michael Sapienza: Proud to welcome leaders and advocates to the 2025 Screen Smart Dinner
Blog
Apr 20, 2025, 14:07
Erika Hamilton: ESMO Breast Cancer 2025 is next month
Cancer Types
Apr 20, 2025, 13:50
Non-Small Cell Lung Cancer: Causes, Symptoms, Diagnosis, Treatment Options, and Latest 2025 Advances in Targeted and Immunotherapy
Blog
Apr 20, 2025, 13:49
Join the global paediatric oncology community in Amsterdam - SIOP
Blog
Apr 20, 2025, 13:31
Estela Rodriguez: It is easy to come up with ideas, hard to implement them
Blog
Apr 20, 2025, 12:54
The invitation to the 6th Annual Meeting in Budapest is waiting for you - SIOP Europe
Blog
Apr 20, 2025, 12:40
Small Cell SMASHERS series highlights the latest discoveries and breakthroughs for SCLC - LUNGevity Foundation
Science
Apr 20, 2025, 12:33
Naveen Pemmaraju: Idarubicin and Cytarabine for patients with relapsed and/or refractory AML
Blog
Apr 20, 2025, 12:23
Proud to have over 70 Cardio-Oncology Centers of Excellence around the world - International Cardio-Oncology Society